These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence and inheritance of C3 types in the Polish population. Schlesinger D; Mańczak M; Hałasa J Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):277-83. PubMed ID: 444041 [TBL] [Abstract][Full Text] [Related]
6. Polymorphism of C3 component of complement in the Polish population. II. Rare phenotypes in C3 system. Mańczak M Arch Immunol Ther Exp (Warsz); 1985; 33(3):443-52. PubMed ID: 4062509 [TBL] [Abstract][Full Text] [Related]
7. Association between the C3F-gene and essential hypertension. Schaadt O; Sørensen H; Krogsgaard AR Clin Sci (Lond); 1981 Dec; 61 Suppl 7():363s-365s. PubMed ID: 7318338 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic. Lydakis C; Beevers M; Beevers DG; Lip GY Int J Clin Pract; 2001; 55(6):361-7. PubMed ID: 11501223 [TBL] [Abstract][Full Text] [Related]
9. Influence of donor C3 allotype on late renal-transplantation outcome. Brown KM; Kondeatis E; Vaughan RW; Kon SP; Farmer CK; Taylor JD; He X; Johnston A; Horsfield C; Janssen BJ; Gros P; Zhou W; Sacks SH; Sheerin NS N Engl J Med; 2006 May; 354(19):2014-23. PubMed ID: 16687714 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of C3 allotypes in patients with nephritic factor. Finn JE; Mathieson PW Clin Exp Immunol; 1993 Mar; 91(3):410-4. PubMed ID: 8443964 [TBL] [Abstract][Full Text] [Related]
11. Hypertension in pregnancy. Analysis of 261 consecutive cases. Svensson A; Andersch B; Hansson L Acta Med Scand Suppl; 1985; 693():33-9. PubMed ID: 3857843 [TBL] [Abstract][Full Text] [Related]
13. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy. Aardenburg R; Spaanderman ME; Ekhart TH; van Eijndhoven HW; van der Heijden OW; Peeters LL BJOG; 2003 Nov; 110(11):1001-6. PubMed ID: 14592585 [TBL] [Abstract][Full Text] [Related]
14. Association between coronary heart disease and the C3F-gene in essential hypertension. Kristensen BO; Petersen GB Circulation; 1978 Oct; 58(4):622-5. PubMed ID: 688571 [TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts. Andrews PA; Finn JE; Mathieson PW; Sacks SH Transplantation; 1995 Dec; 60(11):1342-6. PubMed ID: 8525532 [TBL] [Abstract][Full Text] [Related]
17. Polymorphism of C3 component of complement in the Polish population. I. Population and family studies. Mańczak M Arch Immunol Ther Exp (Warsz); 1984; 32(4):421-30. PubMed ID: 6534316 [TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of C3 allotypes in Chinese patients with immunoglobulin A nephropathy. Finn JE; Li PK; Lai KN; Mathieson PW Am J Kidney Dis; 1994 Apr; 23(4):543-6. PubMed ID: 8154490 [TBL] [Abstract][Full Text] [Related]
20. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3. Poznansky MC; Clissold PM; Lachmann PJ J Immunol; 1989 Aug; 143(4):1254-8. PubMed ID: 2473125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]